ADUCANUMAB FOR ALZHEIMER'S DISEASE? Aducanumab, amyloid, and culture wars

Those who thought that the US Food and Drug Administration (FDA) was a conservative regulator which maintained a high bar have been shocked by its approval of the anti-amyloid antibody aducanumab. There is precedent. Former president Donald Trump championed hydroxychloroquine as a preventative against covid-19. There were no data to suggest that it worked, but under pressure the FDA gave an emergency use authorisation, only to withdraw …